592 related articles for article (PubMed ID: 29580128)
21. MiRNA-101 inhibits breast cancer growth and metastasis by targeting CX chemokine receptor 7.
Li JT; Jia LT; Liu NN; Zhu XS; Liu QQ; Wang XL; Yu F; Liu YL; Yang AG; Gao CF
Oncotarget; 2015 Oct; 6(31):30818-30. PubMed ID: 26360780
[TBL] [Abstract][Full Text] [Related]
22. FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.
Johnson J; Choi M; Dadmanesh F; Han B; Qu Y; Yu-Rice Y; Zhang X; Bagaria S; Taylor C; Giuliano AE; Amersi F; Cui X
Oncotarget; 2016 Nov; 7(46):75729-75738. PubMed ID: 27708239
[TBL] [Abstract][Full Text] [Related]
23. Cytokines driving breast cancer stemness.
Chin AR; Wang SE
Mol Cell Endocrinol; 2014 Jan; 382(1):598-602. PubMed ID: 23562748
[TBL] [Abstract][Full Text] [Related]
24. FGFR4 provides the conduit to facilitate FGF19 signaling in breast cancer progression.
Zhao X; Xu F; Dominguez NP; Xiong Y; Xiong Z; Peng H; Shay C; Teng Y
Mol Carcinog; 2018 Nov; 57(11):1616-1625. PubMed ID: 30074276
[TBL] [Abstract][Full Text] [Related]
25. Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.
Pece S; Disalvatore D; Tosoni D; Vecchi M; Confalonieri S; Bertalot G; Viale G; Colleoni M; Veronesi P; Galimberti V; Di Fiore PP
EBioMedicine; 2019 Apr; 42():352-362. PubMed ID: 30846393
[TBL] [Abstract][Full Text] [Related]
26. Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness.
Ruiz de Garibay G; Herranz C; Llorente A; Boni J; Serra-Musach J; Mateo F; Aguilar H; Gómez-Baldó L; Petit A; Vidal A; Climent F; Hernández-Losa J; Cordero Á; González-Suárez E; Sánchez-Mut JV; Esteller M; Llatjós R; Varela M; López JI; García N; Extremera AI; Gumà A; Ortega R; Plà MJ; Fernández A; Pernas S; Falo C; Morilla I; Campos M; Gil M; Román A; Molina-Molina M; Ussetti P; Laporta R; Valenzuela C; Ancochea J; Xaubet A; Casanova Á; Pujana MA
PLoS One; 2015; 10(7):e0132546. PubMed ID: 26167915
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of Organ-Specific Metastasis of Breast Cancer.
Nolan E; Kang Y; Malanchi I
Cold Spring Harb Perspect Med; 2023 Nov; 13(11):. PubMed ID: 36987584
[TBL] [Abstract][Full Text] [Related]
28. Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer.
Tsang JY; Huang YH; Luo MH; Ni YB; Chan SK; Lui PC; Yu AM; Tan PH; Tse GM
Breast Cancer Res Treat; 2012 Nov; 136(2):407-17. PubMed ID: 23053657
[TBL] [Abstract][Full Text] [Related]
29. Breast Cancer Stem Cells with Tumor- versus Metastasis-Initiating Capacities Are Modulated by TGFBR1 Inhibition.
Fico F; Bousquenaud M; Rüegg C; Santamaria-Martínez A
Stem Cell Reports; 2019 Jul; 13(1):1-9. PubMed ID: 31257133
[TBL] [Abstract][Full Text] [Related]
30. Molecular Basis of Lung Tropism of Metastasis.
Weidle UH; Birzele F; Kollmorgen G; Rüger R
Cancer Genomics Proteomics; 2016; 13(2):129-39. PubMed ID: 26912803
[TBL] [Abstract][Full Text] [Related]
31. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular complexity of breast cancer metastases.
Kimbung S; Loman N; Hedenfalk I
Semin Cancer Biol; 2015 Dec; 35():85-95. PubMed ID: 26319607
[TBL] [Abstract][Full Text] [Related]
33. Breast Cancer: A Molecular and Redox Snapshot.
Raman D; Foo CH; Clement MV; Pervaiz S
Antioxid Redox Signal; 2016 Aug; 25(6):337-70. PubMed ID: 27116998
[TBL] [Abstract][Full Text] [Related]
34. Unravelling site-specific breast cancer metastasis: a microRNA expression profiling study.
Schrijver WA; van Diest PJ; ; Moelans CB
Oncotarget; 2017 Jan; 8(2):3111-3123. PubMed ID: 27902972
[TBL] [Abstract][Full Text] [Related]
35. New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
Buonomo OC; Caredda E; Portarena I; Vanni G; Orlandi A; Bagni C; Petrella G; Palombi L; Orsaria P
PLoS One; 2017; 12(9):e0184680. PubMed ID: 28922402
[TBL] [Abstract][Full Text] [Related]
36. SMARCE1 regulates metastatic potential of breast cancer cells through the HIF1A/PTK2 pathway.
Sethuraman A; Brown M; Seagroves TN; Wu ZH; Pfeffer LM; Fan M
Breast Cancer Res; 2016 Aug; 18(1):81. PubMed ID: 27495308
[TBL] [Abstract][Full Text] [Related]
37. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
[TBL] [Abstract][Full Text] [Related]
38. C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts.
Shu C; Zha H; Long H; Wang X; Yang F; Gao J; Hu C; Zhou L; Guo B; Zhu B
J Exp Clin Cancer Res; 2020 Jan; 39(1):11. PubMed ID: 31931851
[TBL] [Abstract][Full Text] [Related]
39. Cell type of origin as well as genetic alterations contribute to breast cancer phenotypes.
Bhagirath D; Zhao X; West WW; Qiu F; Band H; Band V
Oncotarget; 2015 Apr; 6(11):9018-30. PubMed ID: 25940703
[TBL] [Abstract][Full Text] [Related]
40. Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.
Wang N; Zheng Y; Gu J; Cai Y; Wang S; Zhang F; Chen J; Situ H; Lin Y; Wang Z
Sci Rep; 2017 Nov; 7(1):14513. PubMed ID: 29109519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
